...
首页> 外文期刊>Journal of Medicinal Chemistry >Design and Synthesis of l-Indol-l-yl-propan-2-ones as Inhibitors of Human Cytosolic Phospholipase A_2 alpha
【24h】

Design and Synthesis of l-Indol-l-yl-propan-2-ones as Inhibitors of Human Cytosolic Phospholipase A_2 alpha

机译:设计和合成l-吲哚-1-基丙-2-酮类化合物作为人胞磷脂酶A_2α的抑制剂

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The synthesis and structure-activity relationship study of a series of l-indol-l-yl-3-phenoxypropan-2-one inhibitors of cytosolic phospholipase A_2 alpha (cPLA_2 alpha) are described.The compounds were evaluated in a vesicle assay with isolated cPLA_2 alpha and in cellular assays with intact human platelets.Systematic variation led to 3-methylhydrogen l-[3-(4-decyloxyphenoxy)-2-oxopropyl]indole-3,5-dicarboxylate (57),which revealed the highest activity against the isolated enzyme.With an IC_(50) value of 4.3 nM in this assay,it is one of the most potent in vitro cPLA_2 alpha inhibitors known today.
机译:描述了一系列l-吲哚-1-基-3-基氧基苯氧基丙烷-2-酮抑制剂的胞质磷脂酶A_2α(cPLA_2α)的合成和构效关系。 cPLA_2 alpha以及在完整人类血小板的细胞分析中。系统变异导致3-甲基氢1- [3-(4-癸氧基苯氧基)-2-氧丙基]吲哚-3,5-二羧酸(57),显示出对该试验的IC_(50)值为4.3 nM,是当今已知的最有效的体外cPLA_2α抑制剂之一。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号